Single modality treatment with PD-L1 blockade (p=0.0134) and OX40+4-1BB agonists (p=0.0046) resulted in delayed MC38-CEA tumor growth, while Ad-CEA+N-803 and docetaxel (p>0.05) treatments had little to no effect (figure 2B, C). Here, CEACAM5 is linked to neoplasm.